Clinical Trials Logo

Filter by:
NCT ID: NCT01903759 Terminated - Clinical trials for Patients With Spontaneous Rupture of the Fetal Membranes

Kinetics of Inflammation Markers in Maternal Plasma: Study of the Correlation With the Diagnosis of Chorioamnionitis in Women Hospitalized for Spontaneous Rupture of the Fetal Membranes

Start date: September 2007
Phase: N/A
Study type: Interventional

The principal aim of this study is to help obstetricians to diagnose chorioamniotic infection early, in cases of premature rupture of the fetal membranes before 34 WA, by proposing earlier and more specific markers of infection than FBC and CRP. The aim is to reduce vital and functional risk of acute chorioamnionitis for the mother, the fetus or the newborn,. If the kinetics profile of one or several markers correlates strongly with the diagnosis of chorioamnionitis, it could be used in clinical practice, possibly in the context of another clinical study. The results of the study presented here are destined to be published in obstetrics journals.

NCT ID: NCT01903642 Terminated - Clinical trials for Inflammatory Disease

Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.

Proteome
Start date: March 2010
Phase: N/A
Study type: Interventional

The hypotheses of our research are based on the fact that various pathological states, infection, cancer, inflammatory disease, can induce an inflammatory syndrome, through different pathways, even though the clinical presentation can be identical. The identification of biological markers specific to an etiology would therefore allow a faster diagnosis and improve care for patients. We thus took an interest in the three groups of diseases most frequently responsible for an inflammatory syndrome, infections, cancers and auto-immune diseases. To achieve this, various methods will be used.

NCT ID: NCT01902290 Terminated - Asthma Clinical Trials

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility

Start date: May 22, 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if brodalumab (AMG 827) is safe and effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.

NCT ID: NCT01900665 Terminated - Alzheimer's Disease Clinical Trials

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

EXPEDITION 3
Start date: July 2013
Phase: Phase 3
Study type: Interventional

To test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.

NCT ID: NCT01895582 Terminated - Tuberculosis Clinical Trials

Performance of IGRAs for TB Infection Diagnosis in Elderly

IGRage
Start date: July 17, 2013
Phase:
Study type: Observational

Background: Diagnosis and screening for latent tuberculosis in old patients is of special interest in regards of the morbidity-mortality of this disease in that context. TB-infection diagnosis based on immunological memory detection can be impaired with age. New blood tests (QFTB-G and T-SPOT.TB) specific for MTB infection have not been evaluated in those old patients.The primary endpoint of this study is the evaluation of the IGRAS for active TB diagnosis in patients above 75 years old.

NCT ID: NCT01894204 Terminated - Clinical trials for Idiopathic Pulmonary Embolism

Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism.

PADIS-HTP
Start date: June 27, 2013
Phase: N/A
Study type: Interventional

Forward-looking troop established(constituted) by the patients having been included in the study " PADIS EP ", PHRC on 2006 and 2009, randomized checked(controlled), double-blind, comparing an anticoagulating treatment(processing) extended by coumadine versus placebo during 18 months at patients having had a first episode of EP idiopathique treated(handled) initially 6 months by anti-vitamin K.

NCT ID: NCT01893723 Terminated - General Anesthesia Clinical Trials

Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery

AIVOC-ANI
Start date: June 2012
Phase: N/A
Study type: Interventional

The Physiodoloris (MetroDoloris, Lille, France) monitor, CE marqued, uses the ECG signal in order to compute the Analgesia Nociception Index (ANI) which has been shown to measure the relative parasympathetic tone, and hence to reflect the analgesia/nociception balance during general anesthesia. The primary endpoint of this randomized multicenter study is to measure whether there is a benefit to use the ANI in order to adapt remifentanil administration during propofol anesthesia for laparoscopic surgery. Primary endpoint : lesser proportion of patients presenting with at least one episode of hemodynamic reactivity, hypotension or bradycardia in the ANI guided group vs control group ?

NCT ID: NCT01893385 Terminated - Clinical trials for D Vitamin Deficiency Patients

Vitamin D Supplementation and the Immune Response

Start date: June 2013
Phase: Phase 2
Study type: Interventional

The main objective is to assess the variation in plasma levels of cathelicidin before and after influenza vaccination. All bibliographic data suggests that supplementation vitamin D in the elderly often deficient in this vitamin may have a double interest: - By induction of cathelicidin, assist in anti-infective response in particular to the influenza virus - The normalization of vitamin D status, promote the return to an appropriate immune response limiting excess inflammation and improving capacity to respond. The entire project will collect new information on the merits of the use of vitamin D in aging. A better knowledge of mechanisms involved and the impact of aging on them is a necessary prerequisite the definition of a new strategy using this drug in the elderly particularly fragile in order to improve its autonomy. This definition seems a sociological interest obvious economic knowing the current aging population and its impact future of our health system.

NCT ID: NCT01890408 Terminated - Laparotomy Clinical Trials

Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.

ROPIHEP
Start date: November 2013
Phase: Phase 2
Study type: Interventional

Intravenous morphine Patient-Controlled analgesia is gold standard on post - operative liver resection. But, opioids tend to be ineffective for pain that is associated with movement and have significant short-term side effects including nausea, vomiting, sedation, pruritus, constipation, urinary, retention, and respiratory depression, which are factors that often hinder a patient's recovery. Prospective randomized trials has found continuous wound catheter analgesia as an accepted alternative to IV morphine PCA. The researchers will investigate whether ropivacaine, administered through a wound catheter placed by the surgeon, will reduce morbidity and provide a better recovery.

NCT ID: NCT01889654 Terminated - Clinical trials for Systemic Lupus Erythematosus With or Without Clinical Activity

Anti-nucleosome B Lymphocytes in Lupus

Start date: February 2014
Phase: N/A
Study type: Observational

Lupus disease is characterized by the production of pathogenic autoantibodies, which participate in end-organ damages. The phenotype of B cells producing the pathogenic autoantibodies in lupus patients is today unknown. Antinucleosome antibodies are characteristic of lupus disease.This project proposes to detect antinucleosome B cells in lupus patients and to analyse their phenotype and their frequency.